APO RESEARCH · REPORT
Donepezil
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Product & engineering
Understand the product.
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.
Selected research
Market Structure
Global Donepezil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.
The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.
Read the full market overview
This report provides an overview of the global Donepezil market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Donepezil and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Donepezil sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Donepezil market size, projected growth trends, production technologies, key applications, and end-use industries.
Donepezil Segment by Company
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin
Donepezil Segment by Type
5mg
10mg
23mg
Donepezil Segment by Application
Hospitals
Clinics
Drugstore
Donepezil Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Donepezil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Donepezil market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Donepezil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Donepezil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Donepezil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 10mg
- 23mg
Applications
- Hospitals
- Clinics
- Drugstore
Companies covered
- Eisai
- Pfizer
- Teva
- Sandoz
- Apotex
- Dr Reddy's Laboratories
- Sun Pharmaceutical
- Hansoh Pharma
- Cipla
- ARK PHA.LTD
- Jishengtang Pharma
- Luoxin
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Donepezil Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Donepezil Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Donepezil Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Donepezil Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Donepezil Market Dynamics
- 2.1 Donepezil Industry Trends
- 2.2 Donepezil Industry Drivers
- 2.3 Donepezil Industry Opportunities and Challenges
- 2.4 Donepezil Industry Restraints
3 Donepezil Market by Manufacturers
- 3.1 Global Donepezil Revenue by Manufacturers (2021-2026)
- 3.2 Global Donepezil Sales by Manufacturers (2021-2026)
- 3.3 Global Donepezil Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Donepezil Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Donepezil Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Donepezil Manufacturers, Product Type & Application
- 3.7 Global Donepezil Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Donepezil Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Donepezil Players Market Share by Revenue in 2025
- 3.8.3 2025 Donepezil Tier 1, Tier 2, and Tier 3
4 Donepezil Market by Type
- 4.1 Donepezil Type Introduction
- 4.1.1 5mg
- 4.1.2 10mg
- 4.1.3 23mg
- 4.2 Global Donepezil Sales by Type
- 4.2.1 Global Donepezil Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Donepezil Sales by Type (2021-2032)
- 4.2.3 Global Donepezil Sales Market Share by Type (2021-2032)
- 4.3 Global Donepezil Revenue by Type
- 4.3.1 Global Donepezil Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Donepezil Revenue by Type (2021-2032)
- 4.3.3 Global Donepezil Revenue Market Share by Type (2021-2032)
5 Donepezil Market by Application
- 5.1 Donepezil Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Drugstore
- 5.2 Global Donepezil Sales by Application
- 5.2.1 Global Donepezil Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Donepezil Sales by Application (2021-2032)
- 5.2.3 Global Donepezil Sales Market Share by Application (2021-2032)
- 5.3 Global Donepezil Revenue by Application
- 5.3.1 Global Donepezil Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Donepezil Revenue by Application (2021-2032)
- 5.3.3 Global Donepezil Revenue Market Share by Application (2021-2032)
6 Global Donepezil Sales by Region
- 6.1 Global Donepezil Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Donepezil Sales by Region (2021-2032)
- 6.2.1 Global Donepezil Sales by Region (2021-2026)
- 6.2.2 Global Donepezil Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Donepezil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Donepezil Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Donepezil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Donepezil Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Donepezil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Donepezil Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Donepezil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Donepezil Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Donepezil Revenue by Region
- 7.1 Global Donepezil Revenue by Region
- 7.1.1 Global Donepezil Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Donepezil Revenue by Region (2021-2026)
- 7.1.3 Global Donepezil Revenue by Region (2027-2032)
- 7.1.4 Global Donepezil Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Donepezil Revenue (2021-2032)
- 7.2.2 North America Donepezil Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Donepezil Revenue (2021-2032)
- 7.3.2 Europe Donepezil Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Donepezil Revenue (2021-2032)
- 7.4.2 Asia-Pacific Donepezil Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Donepezil Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Donepezil Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Eisai
- 8.1.1 Eisai Company Information
- 8.1.2 Eisai Business Overview
- 8.1.3 Eisai Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Eisai Donepezil Product Portfolio
- 8.1.5 Eisai Recent Developments
- 8.2 Pfizer
- 8.2.1 Pfizer Company Information
- 8.2.2 Pfizer Business Overview
- 8.2.3 Pfizer Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Pfizer Donepezil Product Portfolio
- 8.2.5 Pfizer Recent Developments
- 8.3 Teva
- 8.3.1 Teva Company Information
- 8.3.2 Teva Business Overview
- 8.3.3 Teva Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Teva Donepezil Product Portfolio
- 8.3.5 Teva Recent Developments
- 8.4 Sandoz
- 8.4.1 Sandoz Company Information
- 8.4.2 Sandoz Business Overview
- 8.4.3 Sandoz Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sandoz Donepezil Product Portfolio
- 8.4.5 Sandoz Recent Developments
- 8.5 Apotex
- 8.5.1 Apotex Company Information
- 8.5.2 Apotex Business Overview
- 8.5.3 Apotex Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Apotex Donepezil Product Portfolio
- 8.5.5 Apotex Recent Developments
- 8.6 Dr Reddy's Laboratories
- 8.6.1 Dr Reddy's Laboratories Company Information
- 8.6.2 Dr Reddy's Laboratories Business Overview
- 8.6.3 Dr Reddy's Laboratories Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Dr Reddy's Laboratories Donepezil Product Portfolio
- 8.6.5 Dr Reddy's Laboratories Recent Developments
- 8.7 Sun Pharmaceutical
- 8.7.1 Sun Pharmaceutical Company Information
- 8.7.2 Sun Pharmaceutical Business Overview
- 8.7.3 Sun Pharmaceutical Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Sun Pharmaceutical Donepezil Product Portfolio
- 8.7.5 Sun Pharmaceutical Recent Developments
- 8.8 Hansoh Pharma
- 8.8.1 Hansoh Pharma Company Information
- 8.8.2 Hansoh Pharma Business Overview
- 8.8.3 Hansoh Pharma Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Hansoh Pharma Donepezil Product Portfolio
- 8.8.5 Hansoh Pharma Recent Developments
- 8.9 Cipla
- 8.9.1 Cipla Company Information
- 8.9.2 Cipla Business Overview
- 8.9.3 Cipla Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Cipla Donepezil Product Portfolio
- 8.9.5 Cipla Recent Developments
- 8.10 ARK PHA.LTD
- 8.10.1 ARK PHA.LTD Company Information
- 8.10.2 ARK PHA.LTD Business Overview
- 8.10.3 ARK PHA.LTD Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 ARK PHA.LTD Donepezil Product Portfolio
- 8.10.5 ARK PHA.LTD Recent Developments
- 8.11 Jishengtang Pharma
- 8.11.1 Jishengtang Pharma Company Information
- 8.11.2 Jishengtang Pharma Business Overview
- 8.11.3 Jishengtang Pharma Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Jishengtang Pharma Donepezil Product Portfolio
- 8.11.5 Jishengtang Pharma Recent Developments
- 8.12 Luoxin
- 8.12.1 Luoxin Company Information
- 8.12.2 Luoxin Business Overview
- 8.12.3 Luoxin Donepezil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Luoxin Donepezil Product Portfolio
- 8.12.5 Luoxin Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Donepezil Value Chain Analysis
- 9.1.1 Donepezil Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Donepezil Production Mode & Process
- 9.2 Donepezil Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Donepezil Distributors
- 9.2.3 Donepezil Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst